Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
UTP14A small subunit processome component, commonly abbreviated as UTP14A, is an essential nucleolar protein involved in ribosome biogenesis through its role in the small subunit (SSU) processome, where it associates with the U3 small nucleolar RNA to mediate 18S rRNA processing[1][2][4]. UTP14A acts as a nucleolar stress sensor, regulating the stability of p53 by promoting its proteasome-dependent degradation and thereby influencing cell cycle progression and apoptosis in response to altered ribosome assembly[1][2]. Overexpression of UTP14A has oncogenic implications, including destabilization of the tumor suppressor p53, stabilization of c-Myc via a deubiquitinase-dependent mechanism, and enhancement of tumor-promoting factors such as PDGFA, contributing to tumor growth, angiogenesis, and metastasis[2]. UTP14A is implicated in multiple cancers and serves as a potential prognostic biomarker due to its elevated expression in tumor tissue and association with poor clinical outcomes[2]. No drugs directly targeting UTP14A have been reported, and its essential cellular role poses challenges for therapeutic development.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on UTP14A small subunit processome component (UTP14A).